Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report) ...

Burris, who remains on the board, retired in 2019 as chief financial officer of Roche Diagnostics Corp. In a filing, Burzic and Burris ask the court to strike defamation claims under California's ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

Roivant, the source of Roche’s TL1A prospect, reported a 21% delta compared to placebo after 12 weeks. Prometheus Biosciences, which Merck acquired, saw a 31% placebo-adjusted rate of endoscopic ...

Cutting corners: Researchers at Imperial College London say an artificial intelligence-based science tool created by Google needed just 48 hours to solve a problem that took them roughly a decade ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...

Sources have also confirmed that Jeffrey Osterman, co-head of Weil’s technology and IP transactions practice, will move to Paul, Weiss, Rifkind, Wharton & Garrison. He follows Elizabeth ...

UBS analyst Matthew Weston maintained a Buy rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF338.00. The company’s shares closed yesterday at $324.00.

But those days had settled down. Or so we thought. This week, Roche made it feel like 2022 again. Just days before the AGBT meeting kicks off in Marco Island, FL, the company hosted a much ...

Roche’s innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...